Altre lingue Actavia Life Sciences, Inc.

Azioni

RASP

US7538881068

Mercato chiuso - OTC Markets Altri mercati azionari 17:25:35 11/04/2024			Variaz. 5gg	Var. 1 gen.
0,0078 ^USD	+1,30%		0,00%	+1,30%

16/02	Actavia Life Sciences, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 dicembre 2023	CI
05/01	Actavia Life Sciences, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Actavia Life Sciences : Change in Certifying Accountants - Form 8-K	10/04
Actavia Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	16/02
Actavia Life Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	05/01
Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	14/08/23
Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	15/05/23
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	02/03/23
Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	02/03/23
RASNA THERAPEUTICS INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	09/02/23
Rasna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	09/02/23
Rasna Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	09/02/23
Rasna Therapeutics : Certificate of Incorporation/Bylaws - Form 8-K	24/01/23
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23/01/23
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20/12/22
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22/08/22
Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22/08/22
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21/06/22
Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	21/06/22
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/06/22
Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021	16/06/22
Rasna Therapeutics : Amendment to Annual Report (Form 10-K/A)	10/06/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Actavia Life Sciences, Inc.

Azioni

RASP

US7538881068

Altre lingue

Filtri